BioPharma Resources

Drug Trial Radar · NCT07786454

A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder

A Phase 3, Multicenter, Open-Label Extension Trial to Evaluate the Safety and Tolerability of SEP-363856 in the Treatment of Adults With Generalized Anxiety Disorder

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,120

Planned (sponsor's estimate)

Start

Oct 8, 2026

Primary completion

May 26, 2029

Study completion Jun 2, 2029

Sponsor

Sponsor type
Industry
First posted
Aug 26, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a global, Phase 3, multicenter, open-label extension trial designed to evaluate the long-term safety, tolerability and efficacy of SEP-363856 administered at doses of 50 milligrams (mg) or 75 mg per day in adult participants with generalized anxiety disorder (GAD) over a treatment period of 26 weeks.

Conditions

  • Generalized Anxiety Disorder

Interventions

  • SEP-363856Drug

    Oral tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs), and TEAEs Leading to DiscontinuationTime frame: Throughout the trial (up to Week 27)

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Neuroscience Solutions, LLC

    Jacksonville, Florida · Recruiting

  • Clinical Neuroscience Solutions Inc. (CNS) - Orlando

    Orlando, Florida · Recruiting

  • Basil Clinical

    Jamaica, New York · Recruiting

  • Manhattan Behavioral Medicine PLLC

    New York, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.